New Patient Required Steps for Ketamine Infusion
These are the steps patients will take with our clinic to determine if ketamine infusions are an appropriate medical intervention
1. Speak with patient coordinator at Restorative Health. The patient coordinator will answer basic questions and explain next steps.
2. The patient will be emailed a link to our new patient forms as well as a ketamine consent form that will need to be completed 24 hours prior to the appointment
3. A calendar invite of the initial ketamine infusion patient evaluation will be sent to the patient notifying the patient of the time and place of the appointment. The approximate length of time of this consultation is 30 minutes. Arriving 10 minutes early to the appointment is appreciated.
4. Procedure-specific forms are completed by the patient. This includes informed consent. The informed consent Includes risks, benefits, and potential side effects. The patient is given a patient education form during the initial consultation.
5. The medical provider performs a 30 minute comprehensive initial new patient consultation and assessment; which includes ruling out diagnosis of current and past medical history that may be contra-indicated for treatment and to ensure patients have a qualifying diagnosis of psychiatric or chronic pain conditions approved for off label use of ketamine treatments.
As part of the comprehensive diagnostic assessment the medical provider does a detailed and thorough history of previous antidepressant treatment to confirm an adequate trial treatment period for patients with depression. Many patients have been referred by their psychiatrist or LSCW.
6. Past medical records are reviewed. All current medications and allergies are reviewed, including history of anesthesia exposure and reaction, hx of substance abuse, and potential interactions with current medications.
7. The patient completes questionnaires to review baseline symptom severity and subsequently after each treatment which are used to later assess response to treatment and change to plan of care.
8. The patients are required to answer a PHQ9 before the initial consultation and before each treatment. Pain assessment and questionnaires are completed for pain patients.
9. Treatment dosage is based on recommendations within the parameters recommended by UpToDate (an evidence-based clinical decision support resource from Wolters Kluwer) and adjusted based on patient response.
10. Treatments are either IV drip infusion or IM; vital signs are taken prior to treatment and patients are monitored by the medical provider throughout the treatment. Driver is required for all patients.